Smad7 Antisense Oligonucleotide in Crohn’s Disease: A Re-Evaluation and Explanation for the Discordant Results of Clinical Trials

In Crohn’s disease (CD) and ulcerative colitis (UC), the major inflammatory bowel diseases (IBD) in human beings, the tissue-damaging inflammatory response is characterized by elevated levels of Suppressor of Mothers Against Decapentaplegic (Smad)7, an inhibitor of the immunosuppressive cytokine Tra...

Descripción completa

Detalles Bibliográficos
Autores principales: Monteleone, Giovanni, Stolfi, Carmine
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Communication
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9864707/
https://www.ncbi.nlm.nih.gov/pubmed/36678723
http://dx.doi.org/10.3390/pharmaceutics15010095

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9864707/
https://www.ncbi.nlm.nih.gov/pubmed/36678723
http://dx.doi.org/10.3390/pharmaceutics15010095

Ejemplares similares